EMA Gives Nod To Additional Sites For Pfizer - BioNTech COVID-19 Vaccine - BioNTech (NASDAQ:BNTX), Pfizer (NYSE:PFE)

European Medical Agency (EMA) has approved additional manufacturing sites to produce Comirnaty, the COVID-19 vaccine developed by Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX).
One site, located in Frankfurt, is operated by Sanofi-Aventis Deutschland GmbH, part of Sanofi SA (NASDAQ:SNY). The other in Hameln is operated by Siegfried Hameln GmbH. Both sites will manufacture the finished product.
These sites will provide up to 50 million additional doses in 2021.
Read Next: EMA Approves Additional Sites To Boost Output Capacity For mRNA-Based COVID-19 Vaccines.
Price Action: PFE shares are down 1.29% at $45.91, while BNTX stock is up 3.88% at $349.29 during the market session on the last check Thursday.

EMA Gives Nod To Additional Sites For Pfizer - BioNTech COVID-19 Vaccine